4-AcO-DMT is a Class A controlled drug in Belize, reached through the ester clause rather than by name. Schedule II Part I paragraph 1 of the Misuse of Drugs Act, Chapter 103, prints «Psilocin.», and Part I paragraph 3 extends the Part to «Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II.» PubChem names psilocin 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol and 4-AcO-DMT [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] acetate, which is the acetic acid ester of the hydroxyl on psilocin, and it is not specified in Part II. Schedule II of the Act is headed «Controlled Drugs» and cites section 4, and section 4(1) provides that the expression controlled drugs means any substance or product for the time being specified in Part I, II or III of Schedule II, and that Class A, Class B and Class C drugs are those specified respectively in Parts I, II and III. Neither 4-AcO-DMT nor acetoxy returns anything in the Act or the Regulations, so this is the clause applied to a structure and not a printed name. Schedule I paragraph 1(b) of the Regulations, a generic clause for compounds derived from tryptamine or a ring hydroxy tryptamine by alkyl substitution at the side chain nitrogen and no other substitution, has no counterpart in Part I of the Act and is not the route relied on here. The Act read is Chapter 103 of the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, whose Schedule II carries the footnote «This Schedule was amended by Statutory Instrument No. 5 of 2014 and Statutory Instrument No 132 of 2020.» The two later amending Acts, No. 25 of 2023 and No. 26 of 2024, were read too: the first amends section 48(4) and the second repeals section 28B, and neither touches section 4, section 7, section 18, section 28 or any Schedule.
Belize, Misuse of Drugs Act, Chapter 103, Schedule II Part I paragraphs 1 and 3, the entry «Psilocin.», in the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, with sections 4, 7, 18 and 28 and Schedule III of the same volume · agm.gov.bz · Misuse of Drugs Regulations, Schedule I paragraphs 1(a) and 3, in the Subsidiary Laws of Belize, Revised Edition 2020 · agm.gov.bz · Misuse of Drugs (Amendment of Second Schedule) Order 2020, S.I. 132 of 2020, https://www.agm.gov.bz/uploads/laws/6a67dbac595cd_SI_No._132_of_2020_Misuse_of_Drugs__Amendment_of_Second_Schedule__Order__2020.pdf · Misuse of Drugs (Amendment) Act No. 25 of 2023, https://www.agm.gov.bz/uploads/laws/64baeb84e3181_Act_No._25_of_2023_Misuse_of_Drugs__Amendment__Act__2023..pdf · Misuse of Drugs (Amendment) Act No. 26 of 2024, https://www.agm.gov.bz/uploads/laws/67fe7a0e1645c_Act_No._26_of_2024_Misuse_of_Drugs_Amendment_Act-2024.pdf · Senior Courts of Belize, Practice Direction No. 7 of 2025, Sentencing Guidelines for Drug Offences, https://www.agm.gov.bz/uploads/laws/67991ef1f0520_Practice_Direction_No._7_of_2025_Sentencing_Guidelines_for__Drug_Offences.pdf · for comparison only, the Misuse of Drugs Act 1990, Act 22 of 1990, as UNODC holds it, https://www.unodc.org/cld/uploads/res/document/the-misuse-of-drugs-act-1990_html/The_Misuse_of_Drugs_Act_1990.pdf · PubChem, 4-AcO-DMT CID 15429212, https://pubchem.ncbi.nlm.nih.gov/compound/15429212 · PubChem, psilocin CID 4980, https://pubchem.ncbi.nlm.nih.gov/compound/4980 · read as at 3 October 2026 · Verified October 3, 2026
5-MeO-DMT is a Class A controlled drug in Belize, reached through the ether clause rather than by name. Schedule II Part I paragraph 1 of the Misuse of Drugs Act, Chapter 103, prints «Bufotenine.» in its left column, and Part I paragraph 3 extends the Part to «Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II.» PubChem names bufotenine 3-[2-(dimethylamino)ethyl]-1H-indol-5-ol and 5-MeO-DMT 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine: the same molecule with the hydroxyl at ring position five carrying a methyl group, which is the methyl ether of bufotenine, and it is not specified in Part II. Schedule II of the Act is headed «Controlled Drugs» and cites section 4, and section 4(1) provides that the expression controlled drugs means any substance or product for the time being specified in Part I, II or III of Schedule II, and that Class A, Class B and Class C drugs are those specified respectively in Parts I, II and III. The Act prints «N,N-Diethyltryptamine.», carries «N,N-Dimethyltryptamine.» in its text layer, and has no general tryptamine clause, so the ether route is the only one. 5-MeO-DMT itself returns nothing in the Act or the Regulations. Schedule I paragraph 1(b) of the Regulations, a generic clause for compounds derived from tryptamine or a ring hydroxy tryptamine by alkyl substitution at the side chain nitrogen and no other substitution, has no counterpart in Part I of the Act and is not the route relied on here. The Act read is Chapter 103 of the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, whose Schedule II carries the footnote «This Schedule was amended by Statutory Instrument No. 5 of 2014 and Statutory Instrument No 132 of 2020.» The two later amending Acts, No. 25 of 2023 and No. 26 of 2024, were read too: the first amends section 48(4) and the second repeals section 28B, and neither touches section 4, section 7, section 18, section 28 or any Schedule.
Belize, Misuse of Drugs Act, Chapter 103, Schedule II Part I paragraphs 1 and 3, the entry «Bufotenine.», in the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, with sections 4, 7, 18 and 28 and Schedule III of the same volume · agm.gov.bz · Misuse of Drugs Regulations, Schedule I paragraphs 1(a) and 3, in the Subsidiary Laws of Belize, Revised Edition 2020 · agm.gov.bz · Misuse of Drugs (Amendment of Second Schedule) Order 2020, S.I. 132 of 2020, https://www.agm.gov.bz/uploads/laws/6a67dbac595cd_SI_No._132_of_2020_Misuse_of_Drugs__Amendment_of_Second_Schedule__Order__2020.pdf · Misuse of Drugs (Amendment) Act No. 25 of 2023, https://www.agm.gov.bz/uploads/laws/64baeb84e3181_Act_No._25_of_2023_Misuse_of_Drugs__Amendment__Act__2023..pdf · Misuse of Drugs (Amendment) Act No. 26 of 2024, https://www.agm.gov.bz/uploads/laws/67fe7a0e1645c_Act_No._26_of_2024_Misuse_of_Drugs_Amendment_Act-2024.pdf · Senior Courts of Belize, Practice Direction No. 7 of 2025, Sentencing Guidelines for Drug Offences, https://www.agm.gov.bz/uploads/laws/67991ef1f0520_Practice_Direction_No._7_of_2025_Sentencing_Guidelines_for__Drug_Offences.pdf · for comparison only, the Misuse of Drugs Act 1990, Act 22 of 1990, as UNODC holds it, https://www.unodc.org/cld/uploads/res/document/the-misuse-of-drugs-act-1990_html/The_Misuse_of_Drugs_Act_1990.pdf · PubChem, 5-MeO-DMT CID 1832, https://pubchem.ncbi.nlm.nih.gov/compound/1832 · PubChem, bufotenine CID 10257, https://pubchem.ncbi.nlm.nih.gov/compound/10257 · read as at 3 October 2026 · Verified October 3, 2026
N, N-Dimethyltryptamine is printed in Belize's Misuse of Drugs Regulations at Schedule I paragraph 1(a), in the Misuse of Drugs Act Chapter 103 volume of the Subsidiary Laws of Belize, Revised Edition 2020, which shows the subsidiary laws as at 31 December 2020. It is the fourth of five chemical names at the foot of the paragraph, after Tenocyclidine, the bromo dimethoxy phenethylamine entry and N, N-Diethyltryptamine, and before the dimethoxy dimethylphenethylamine line. That schedule's heading reads «CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15, 16, 18, 19, 20, 23, 25 AND 26.» The subsidiary law made under Chapter 103 therefore calls what it lists a controlled drug, and this substance is one of them. The comma and space inside the printed name are the volume's own setting. Paragraph 1(b) then reaches any compound derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with alkyl substituents and no other substituents, which is why the other tryptamine rows in this batch are decided one at a time rather than by family. No class is given here. Class follows from Part I, Part II or Part III of the Act's Second Schedule under section 4, and the subsidiary volume read for this row prints no part of that schedule and uses the words Class A, Class B and Class C nowhere at all. The schedule placement in this cell is read off the instrument and is not printed in the quoted dossier extract, which names the Act's schedules only as a range.
Belize, Misuse of Drugs Regulations, Schedule I paragraph 1(a), in the Misuse of Drugs Act Chapter 103 volume of the Subsidiary Laws of Belize, Revised Edition 2020, which shows the subsidiary laws as at 31 December 2020 · agm.gov.bz · the Act's offence and penalty provisions were read in the Misuse of Drugs Act 1990, Act 22 of 1990, as UNODC holds it, https://www.unodc.org/cld/uploads/res/document/the-misuse-of-drugs-act-1990_html/The_Misuse_of_Drugs_Act_1990.pdf · that Act text stops partway through section 28 and carries none of its own three schedules, so no class and no ordinary possession maximum is taken from it · read as at 22 September 2026 · Verified September 21, 2026
Psilocybin is a Class A controlled drug in Belize, reached through an ester clause rather than by name. Schedule II Part I paragraph 1 of the Misuse of Drugs Act, Chapter 103, prints «Psilocin.» in its right column between «Properidine» and «Racemethorphan.», and Part I paragraph 3 extends the Part to «Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II.» PubChem names psilocin 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol and psilocybin [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate, which is the phosphate ester of the hydroxyl on psilocin, and psilocybin is not specified in Part II. The United Kingdom statute book uses the same description in its own Class A list, where section 21 of the Drugs Act 2005 inserted «Fungus (of any kind) which contains psilocin or an ester of psilocin.» Schedule II of the Act is headed «Controlled Drugs» and cites section 4, and section 4(1) provides that the expression controlled drugs means any substance or product for the time being specified in Part I, II or III of Schedule II, and that Class A, Class B and Class C drugs are those specified respectively in Parts I, II and III. The word psilocybin itself returns nothing in the Act or the Regulations. What this cell does not settle is the mushroom. Belize Schedule II prints no fungus entry, and whether a fresh or dried mushroom is a «preparation or other product containing» psilocin under Part I paragraph 5 is not stated in the instrument, so the Class A answer here is for the compound. The Act read is Chapter 103 of the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, whose Schedule II carries the footnote «This Schedule was amended by Statutory Instrument No. 5 of 2014 and Statutory Instrument No 132 of 2020.» The two later amending Acts, No. 25 of 2023 and No. 26 of 2024, were read too: the first amends section 48(4) and the second repeals section 28B, and neither touches section 4, section 7, section 18, section 28 or any Schedule.
Belize, Misuse of Drugs Act, Chapter 103, Schedule II Part I paragraphs 1 and 3, the entry «Psilocin.», in the Substantive Laws of Belize, Revised Edition 2020, showing the substantive laws as at 31 December 2020, with sections 4, 7, 18 and 28 and Schedule III of the same volume · agm.gov.bz · Misuse of Drugs Regulations, Schedule I paragraphs 1(a) and 3, in the Subsidiary Laws of Belize, Revised Edition 2020 · agm.gov.bz · Misuse of Drugs (Amendment of Second Schedule) Order 2020, S.I. 132 of 2020, https://www.agm.gov.bz/uploads/laws/6a67dbac595cd_SI_No._132_of_2020_Misuse_of_Drugs__Amendment_of_Second_Schedule__Order__2020.pdf · Misuse of Drugs (Amendment) Act No. 25 of 2023, https://www.agm.gov.bz/uploads/laws/64baeb84e3181_Act_No._25_of_2023_Misuse_of_Drugs__Amendment__Act__2023..pdf · Misuse of Drugs (Amendment) Act No. 26 of 2024, https://www.agm.gov.bz/uploads/laws/67fe7a0e1645c_Act_No._26_of_2024_Misuse_of_Drugs_Amendment_Act-2024.pdf · Senior Courts of Belize, Practice Direction No. 7 of 2025, Sentencing Guidelines for Drug Offences, https://www.agm.gov.bz/uploads/laws/67991ef1f0520_Practice_Direction_No._7_of_2025_Sentencing_Guidelines_for__Drug_Offences.pdf · for comparison only, the Misuse of Drugs Act 1990, Act 22 of 1990, as UNODC holds it, https://www.unodc.org/cld/uploads/res/document/the-misuse-of-drugs-act-1990_html/The_Misuse_of_Drugs_Act_1990.pdf · PubChem, psilocybin CID 10624, https://pubchem.ncbi.nlm.nih.gov/compound/10624 · PubChem, psilocin CID 4980, https://pubchem.ncbi.nlm.nih.gov/compound/4980 · United Kingdom, Drugs Act 2005 section 21, https://www.legislation.gov.uk/ukpga/2005/17/section/21 · read as at 3 October 2026 · Verified October 3, 2026